KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Shares Outstanding (Weighted Average) (2016 - 2025)

Charles River Laboratories International (CRL) has 10 years of Shares Outstanding (Weighted Average) data on record, last reported at $49.6 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 3.53% year-over-year to $49.6 million; the TTM value through Dec 2025 reached $49.6 million, down 3.53%, while the annual FY2025 figure was $49.6 million, 3.53% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $49.6 million in Q4 2025 per CRL's latest filing, roughly flat from $49.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $51.5 million in Q2 2024 and bottomed at $49.1 million in Q2 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $50.7 million, with a median of $50.8 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 1.88% in 2021, then decreased 4.55% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $50.3 million in 2021, then rose by 1.03% to $50.8 million in 2022, then rose by 0.82% to $51.2 million in 2023, then rose by 0.3% to $51.4 million in 2024, then decreased by 3.53% to $49.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $49.6 million in Q4 2025, $49.7 million in Q3 2025, and $49.1 million in Q2 2025.